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Abstract
Whether stromal components facilitate growth, invasion, and dissemination of cancer cells or suppress neoplastic lesions
from further malignant progression is a continuing conundrum in tumor biology. Conceptualizing a dynamic picture of
tumorigenesis is complicated by inter-individual heterogeneity. In the post genomic era, unraveling such complexity
remains a challenge for the cancer biologist. Towards establishing a functional association between cellular crosstalk and
differential cancer aggressiveness, we identified a signature of malignant breast epithelial response to stromal signaling.
Proximity to fibroblasts resulted in gene transcript alterations of .2-fold for 107 probes, collectively designated as
Fibroblast Triggered Gene Expression in Tumor (FTExT). The hazard ratio predicted by the FTExT classifier for distant relapse
in patients with intermediate and high grade breast tumors was significant compared to routine clinical variables (dataset 1,
n=258, HR – 2.11, 95% CI 1.17–3.80, p-value 0.01; dataset 2, n=171, HR - 3.07, 95% CI 1.21–7.83, p-value 0.01). Biofunctions
represented by FTExT included inflammatory signaling, free radical scavenging, cell death, and cell proliferation. Unlike
genes of the ‘proliferation cluster’, which are overexpressed in aggressive primary tumors, FTExT genes were uniquely
repressed in such cases. As proof of concept for our correlative findings, which link stromal-epithelial crosstalk and tumor
behavior, we show a distinctive differential in stromal impact on prognosis-defining functional endpoints of cell cycle
progression, and resistance to therapy-induced growth arrest and apoptosis in low vs. high grade cancer cells. Our
experimental data thus reveal aspects of ‘paracrine cooperativity’ that are exclusively contingent upon the
histopathologically defined grade of interacting tumor epithelium, and demonstrate that epithelial responsiveness to the
tumor microenvironment is a deterministic factor underlying clinical outcome. In this light, early attenuation of epithelial-
stromal crosstalk could improve the management of cases prone to be clinically challenging.
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Introduction
It is widely believed that the local microenvironment of host
tissue is an active participant throughout cancer development and
progression [1]. In this milieu, interactive exchanges between
stroma and tumor cells might influence survival, growth, and
dissemination [2]. Autocrine stromal chemokines, and paracrine
TGFb signals are well known pro-tumorigenic mediators [3–8]. In
breast tumors, fibroblasts generally represent the most abundant
cell type in the stroma, often referred to as the ‘reactive stroma’,
highly enriched in, type I and VI collagen, laminin, entactin,
heparan-sulfate proteoglycans and fibrin [9]. Tumor-derived
fibroblasts from different organs display considerable variability
in transcriptional profiles [10], and significant variations occur in
stromal gene expression within tumors of the same organ system,
often in association with clinicopathologic parameters. For
example, overexpression of CD10, and PDGFß receptor in breast
cancer stroma is characteristic of high histologic grade [11,12].
Fibroblast-associated signatures and their clinical correlation with
outcome in cancer patients [13,14], suggest that an altered tumor
stroma is a result of ‘cooperative crosstalk’ with carcinoma cells.
A comprehensive effort to reveal the underpinnings of stromal-
epithelial crosstalk within solid tumors could assist in the
identification of a broader spectrum of targetable molecular
determinants of patient outcome. It is conceivable that aggressive
phenotypes of tumor cells often represent a localized response to
microenvironmental signals [15]. However, despite transient in
vitro induction, stromal-epithelial crosstalk has long-lasting func-
tional effects on tumorigenicity and metastatic potential of cells
inoculated into experimental animals [16]. In the search for
specific phenotypic effects, in vitro interactions between fibroblasts
and breast epithelial cells previously attempted were limited to
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derived from aggressive high grade tumors and metastatic
effusions [17–19], or from nonmalignant human breast tissue
[20]. Interpretation of such data is encumbered by the lack of a
wide, disease-based spectrum of surrogate models of human
cancer. Thus unequivocal conclusions regarding an association
between clinical heterogeneity and the functional biology
underlying stromal-epithelial signaling remain elusive. A critical
prerequisite for analyzing the interaction between various cellular
subsets within tumor tissue is the availability of live interactive
components fractionated from fresh surgical discard tissue in
quantities sufficient for robust data collection and hypothesis
generation. Likewise, to attain translational insights through
experimental simulation, it is critically important to incorporate
a cellular repertoire, which reflects the breadth of clinical
variability contributed by epithelial and stromal elements within
tumor tissue. By facilitating direct crosstalk between novel primary
tumor cell lines of wide ranging clinicopathology [21] and multiple
independent samples of nonmalignant or tumor tissue-derived
fibroblasts, our study has aimed towards an improved under-
standing of cancer biology and its application in the following
ways. First, a set of genes is identified, whose expression is
consistently altered through paracrine interactions. Next, the role
of such a stromally induced tumor cell response in promoting
disease severity is illustrated through its correlation with clinical
outcome. Finally, a direct functional basis for varying clinical
outcome associated with tumor responsiveness to stromal signaling
is demonstrated by shifts in cell cycle kinetics, apoptotic evasion,
ROS reduction, and neutralization of the growth inhibitory effects
of hormonal cancer therapy. Our demonstration of grade-
associated variability in the dynamic reprogramming of cancerous
epithelium by the stromal microenvironment enhances the scope
of classical cancer pathobiology, and suggests new targets for
tumors refractory to current treatments. Moreover, detection of
patterns of paracrine responsiveness at early stages might reveal
the propensity for progression from premalignant, and preinvasive
disease to advanced lesions.
Results
Identification of FTExT - a gene expression profile
depicting malignant cell response to stromal signaling
A differential expression profile between primary breast tumor
cell lines alone (T none) and those propagated in the presence of
breast tumor fibroblasts (T+TF) was defined by a significant gene
list comprised of 482 probe sets with an adjusted p-value,0.05,
where 7 independent primary tumor cell lines were denoted as T,
and primary tumor-derived fibroblasts as TF. Expression profiles
for 3/7 cell lines were acquired with 2 independent fibroblasts
samples. A heatmap, largely reflecting transcriptional repression
by tumor-fibroblast coculture (Figure 1A) includes 107 probe sets,
with .2 fold change in gene expression (Table S1). This group of
genes, which displayed significant negative fold-change in tumor
cells, and designated as Fibroblast Triggered Gene Expression in
Tumor (FTExT), was investigated further. Upregulated probe sets
within the significant gene list did not meet our selection criteria
for fold change, and were not considered for further study.
Enriched categories of biological functions associated with FTExT
genes were determined by Ingenuity Pathway Analysis, and
primarily involved inflammatory response, cell proliferation, cell
death, and free radical scavenging (Figure 1B, and Figure S1).
Additional approaches to evaluate the diversity of stromal
influence, included: (1) comparative analysis of tumor-derived
significant gene list (482 probe sets) with array data from stromal-
epithelial cocultures isolated from 8 independent nonmalignant
breast tissue samples. Gene expression patterns were distinctive
between cocultured malignant vs. nonmalignant breast epithelial
cells (Figure 1C). Whereas nonmalignant epithelial cells cocultured
with corresponding nonmalignant fibroblasts displayed relative
uniformity in responsiveness, wide heterogeneity was observed in
tumor-derived stromal-epithelial cocultures (2) QPCR analysis of
11 FTExT genes in an independent set of 6 primary tumor-
derived epithelial cell lines cocultured with 4 previously untested
tumor-derived fibroblasts. Similar to the above-mentioned array
data, a gene-by-gene quantitative analysis confirmed induction of
changes in test gene expression relative to the housekeeping gene,
ACTB, within cocultured tumor cells (from 4 matched, and 2
unmatched cocultures) (Figure 1D).
FTExT variation and association with clinical outcome of
primary breast cancer
To determine the clinical relevance of phenotypic changes
directly induced by stromal crosstalk, the classification power of
FTExT (107 probe sets) was tested in conjunction with array data
from 2 independent breast cancer datasets. Distant metastasis-free
survival (DMFS) was used as an endpoint for patient outcome. In
the GSE6532 dataset [22], tumors with poor prognosis displayed
significantly greater FTExT gene repression in comparison to
those with good prognosis (n=401; p=0.031, Figure 2A – left
panel). The stratification power of FTExT encompassed tumors of
all grades. Moreover, the classifier further improved the
subclassification of the subset comprised only of intermediate
and high grade tumors (n=258; p=0.011, Figure 2A – right
panel). In other words, FTExT reliably identified patients who did
poorly in situations where traditional histopathology based
prognostication was limited in terms of providing an accurate
prediction. Reproducibility of the FTExT classifier performance
was further demonstrated in an independent dataset [23] –
GSE11121 across all grades (n=200; p=0.013, Figure 2B - left
panel) as well as in a separate analysis of intermediate and high
grade breast cancer (n=171; p=0.013, Figure 2B – right panel).
Notably in all analyses, FTExT was a better independent predictor
of the outcome of intermediate and high grade cases compared to
conventional prognostic parameters, such as, tumor grade, ER
status, lymph node positivity, and tumor size (Table 1).
Our combined coculture gene expression data and FTExT
analysis of primary tumor datasets demonstrated that this
stromally induced profile was manifested as a continuum. On
one extreme were relatively unchanged patterns of gene expression
characteristic of nonmalignant cocultures, shifting to minimal
repression of FTExT genes within primary tumors associated with
good clinical outcome, while on the other extreme were highly
repressed expression profiles within tumors conferring poor patient
outcome.
Induction of a wide spectrum of functional changes in
malignant cells by stromal fibroblast crosstalk
In an effort to reveal the biological significance of stromally
induced phenotypes as a determinant of clinical outcome, we
employed novel primary breast tumor cell lines of varying
histologic grade [21] in a variety of functional tests. Reflecting
the enriched biofunction analysis of FTExT genes, robust assays
were prioritized, where quantifiable endpoints could be employed,
and which could be readily conducted in view of limitations in the
availability of finite-life stromal cultures. Specifically, changes in
the functional endpoints of major cellular programs such as
hyperactivated proliferation kinetics; oxidative stress neutraliza-
Cellular Crosstalk Determines Cancer Outcome
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e20016Figure 1. Gene expression changes induced in primary breast cancer cells by fibroblast coculture. A. Hierarchical clustering of primary
breast cancer cell lines as control monoculture, and in coculture with tumor-derived fibroblasts. Note independent clusters portraying distinctive
stromally induced expression patterns in tumor cells reflected by 482 significant probe sets. B. Enriched categories of bio-functions represented by
107 probe sets, with .2 fold change in gene expression, designated as FTExT. Bars are grouped and colored according to bio-function categories.
Each bar represents an enrichment test p-value of a bio-function. C. Analysis of 482 significant probe sets averaged over multiple epithelial cell
cultures derived from malignant (red) and nonmalignant breast tissue (green) in the presence (y-axis) or absence (x-axis) of stromal coculture. The
black dotted line represents x=y. Tumor cells display greater deviation from this line, i.e. between control and coculture whereas the expression
patterns of cocultured nonmalignant epithelial cells shows minimal deviation from control. D. Scatter plot of relative transcript levels of 11 FTExT
genes measured by QPCR in an independent set of 6 primary breast tumor cell lines cocultured with one of 4 tumor-derived fibroblast (TF) samples.
Data represent ACTB normalized expression of test gene in cocultured tumor cells relative to control. Note range of expression for each test gene.
doi:10.1371/journal.pone.0020016.g001
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cells cocultured with fibroblasts derived from malignant or
nonmalignant human breast tissue:
(1) Reprogrammed cell cycle distribution of cancerous
cells. Ten independent primary breast cancer cell lines under
control and TF-coculture conditions were labeled with BrdU, and
analyzed by FACS. Cell cycle changes induced by coculture are
summarized in Table 2. Dot plots of representative cell lines are
illustrated in Figure 3A. The data demonstrated distinctive grade-
dependent cell cycle profiles. In response to stromal cell signaling,
grade 1 (CCdl22, CCdl68) and grade 2 (CCdl1570) tumor derived
cell lines displayed either (a) no significant change in cell cycle
distribution compared to non cocultured controls, or (b) induction
of cell cycle arrest in the G2/M-phase, indicating activation of a
post-replicative/DNA repair checkpoint. In contrast, grade 3
tumor cells (CCdl54, CCdl257, CCdl675), including a high grade
ductal carcinoma in situ (DCIS)-derived cell line (CCdl1797) and
additional grade 2 tumor lines (CCdl66, CCdl329, CCdl1599)
displayed a significant increase in the S-phase population,
indicative of (a) DNA synthesis/replication defects due to stalling
of replication forks, or (b) a faster cell proliferation rate. Notably,
the specificity of tumor cell response was common between
independent fibroblast samples.
(2) Dramatic alterations in the rate of tumor cell
proliferation. To confirm that an increased S-phase fraction in
response to stromal signaling in grade 3 tumor cells indeed
represented a faster proliferation rate compared to grade 1 cell
lines, representatives of each group in coculture with 2 independent
TF samples were pulsed with BrdU at multiple time points over a
1 hour time period. FACS measurements of the BrdU-
incorporating cell fraction over time provided a reliable estimate
of the rate of DNA synthesis in tumor cells with and without
exposure to fibroblast signaling. Proliferation kinetics of grade 1
(CCdl22) cocultures further confirmed a previously observed
fibroblast-induced G2/M arrest. Cell cycle arrest was maintained
during the entire experimental time course, leading to a marked
Figure 2. FTExT gene transcript levels and association with clinical outcome. A. Dataset 1 (GSE6532) – FTExT classifier predicts good vs.
poor outcome for the endpoint of distant metastasis-free survival (DMFS) (n=401, left panel). FTExT based stratification of patients diagnosed with
grade 2 (intermediate) and 3 (high) tumors (n=258, right panel). B. Dataset 2 (GSE11121) – FTExT prediction of DMFS in an independent dataset
(n=200, left panel). Confirmation of FTExT based stratification of patients diagnosed with grade 2 and 3 tumors (n=171, right panel).
doi:10.1371/journal.pone.0020016.g002
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(Figure 3B). In striking contrast, in grade 3 (CCdl675) cocultures, a
dramatic increase of at least 47% and up to 60% occurred in the
rate of replication based on the slopes of the growth curves
compared to control cells. Induction of a slower or faster
proliferation rate in grade 1 and grade 3 tumor cells, respectively,
was consistent between independent fibroblast samples.
(3) Stroma-assisted protection from apoptotic cell
death. To evaluate whether stromal signaling enhances survival
and propagation of cocultured tumor cells, the ESR1 antagonist, 4-
hydroxy tamoxifen (OHT), known to exert its anti tumor effects by
oxidative stress induction and subsequent apoptosis, was used to
initiate cell death in cell lines, which displayed an increase in percent
S-phase in response to coculture. Cell lines derived from both grade 2
(CCdl329 and CCdl1599) and grade 3 (CCdl675) tumors were
evaluated. An experimentally derived apoptotic index comparing a
singleconcentration of 10 mM OHT with no OHT control enabled a
standardized assay wherein the relative protective effects of stromal
coculture could be measured by Annexin-V staining. First, a
comparison between baseline apoptosis in tumor cell lines
(CCdl675, CCdl329 and CCdl1599) cultured alone or as cocultures
with 3 independent fibroblast sources (1 reduction mammoplasty-
derived, designated as EF, and 2 tumor derived or TF) demonstrated
a stromally induced protective effect (Figure 4A). The apoptotic
fraction was reduced by 30–60% in grade 2 cell lines (CCdl1599 -
p,0.002; CCdl329 - p,0.001), and by 85% in grade 3 cells
(CCdl675 - p,0.005). More significantly, the dramatic spike in
OHT-induced cell death was also suppressed by prior exposure of all
3 tumor cell lines to fibroblast coculture. Stromal fibroblasts of both
malignant and nonmalignant derivation were equally effective in
eliciting apoptosis suppression in tumor cells (p,0.001) (Figure 4B).
WhileitispossiblethatthevariabilityinthecellularresponsetoOHT
evident in coculture is largelya reflection of differential ESR1 activity,
our data strongly suggest that growth inducing paracrine signaling in
tumor cells could potentially alter sensitivity to hormonal therapy and
play a role in the acquisition of a resistant phenotype.
(4) Reduction of oxidative stress within tumor cells. The
mean fluorescence intensity of C400 staining served well as an
indicator of endogenous ROS levels, albeit they are generally low
in tumor cell lines compared to inflammatory cell types. A marked
decline in OHT-induced ROS accumulation was observed in
tumor cell lines (CCdl1599, CCdl329, and CCdl675) cocultured
prior to drug treatment (Figure 4C). The average reduction in
ROS with coculture was 34% (p,0.0001). All 3 cell lines were
consistent in their degree of response to malignant and
nonmalignant tissue-derived fibroblasts.
Cell cycle analysis demonstrated an OHT-induced G1 phase
arrest in all tumor cell lines tested, which ranged from a 35% to
73% increase in this fraction (p,0.001). Additionally, a mild
accumulation in the G2/M fraction was also evident in 2/3 tumor
cell lines (p,0.02) in the presence of the therapeutic hormone
antagonist. In cocultures of 2/3 tumor cell lines (CCdl1599,
CCdl675), the G1-arrested fraction declined significantly despite
OHT exposure (p,0.001) (Figure 4D). The protective effect of
fibroblast coculture was not as apparent in the CCdl329 line since
it displayed relative resistance to OHT treatment as indicated by
the lowest increase in the G1 fraction – suggesting that the G1/S
checkpoint may be defective in these cells. Interestingly, despite
the induction of only a mild G1 arrest, CCdl329 cells were
responsive to OHT-induced apoptosis (Figure 4B). Such differen-
tial responses to OHT suggest other sources of variability in breast
tumors, which further modify the outcome of tumor-stroma
interactions, and reflect additional sources of heterogeneity.
Taken together, our data demonstrates that fibroblast coculture
facilitated a parallel reduction in 3 independent but closely related
parameters of OHT-induced damage: ROS accumulation, G1
arrest, and apoptotic cell death within an aggressive subset of
primary breast tumor derived cell lines. However, despite tumor
promoting responsiveness displayed by these cell lines, marked
variation was evident. CCdl329 cells effectively evaded OHT-
induced apoptosis even though G1 arrest in the presence of the
drug was only partially overcome by coculture. In contrast,
CCdl675 cells were relatively deficient in surmounting the
apoptotic burden despite the observed ROS reduction and a
striking decline in the G1 and G2/M arrested fraction, consistent
with our observations of deficient repair culminating in increased
genomic instability (data to be published elsewhere).
Stromal fibroblast induced functional impact is reversible
Finally, to evaluate the reversibility of distinctive and determin-
istic endpoints of stromally induced growth aggressiveness, tumor
cells were analyzed over a short-term recovery period for reversal of
cell cycle changes, and induction of cell death, after coculture
conditions were discontinued (Figure 5A). Removal of the stromal
influence from grade 3 (CCdl675) cocultures reversed the striking S-
phase increase over control during the 48 hr test period. However,
enhancement in apoptotic cell death was not detected during this
period (data not shown), confirming that coculture induced increase
in the BrdU-labeled fraction of tumor cells represented a larger
cycling population, instead of accumulation in S-phase due to
replication-arrest and fork stalling. In the event of the latter
possibility, termination of coculture would have led to cell cycle
progression in tumor cells harboring an unreplicated set of
chromosomes, culminating in mitotic catastrophe and cell death.
In grade 1 tumor cells (CCdl22), which responded to coculture by
displaying an average increase of 64% in the G2/M arrested
population relative to control (p,0.001), cell cycle re-entry was
observed upon fibroblast removal. However, as the culture reached
confluence within the experimental time frame, a subsequent G0/
G1 arrest was apparent in both control and cocultured grade 1 cells,
strongly suggesting that (a) these tumor cells were likely DNA repair
proficient, as removal of stromal effectors surmounted the G2
checkpoint, and that (b) the growth potential was intact, but
responsive to negative regulation by paracrine signaling. Had the
G2/M checkpoint not been reversible but due instead to the onset
of mitotic arrest in cocultures, it would have resulted in apoptotic
cell death, detectable as a substantial increase in the subG1
population within the test period.
Table 1. Distant metastasis-free survival prediction for
intermediate and high grade breast cancer.
Predictor Log-rank p value Hazard ratio (95% CI)
Dataset 1
FTExT 0.01 2.10 (1.17–3.79)
Grade 2 vs. 3 0.86 1.04 (0.62–1.76)
ER 0.62 1.17 (0.61–2.24)
LN 0.07 1.53 (0.95–2.45)
Size (.2 cm) 0.03 1.69 (1.03–2.8)
Dataset 2
FTExT 0.01 3.07 (1.20–7.82)
Grade 2 vs. 3 0.03 1.98 (1.03–3.82)
Size (.2 cm) 0.23 1.44 (0.78–2.65)
doi:10.1371/journal.pone.0020016.t001
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PLoS ONE | www.plosone.org 5 May 2011 | Volume 6 | Issue 5 | e20016Figure 3. Influence of stromal-epithelial crosstalk on proliferation rate of tumor cells of varying histologic grade. A. Cell cycle analysis
of primary breast tumor cell lines in coculture with 2 independent fibroblast samples, TF1, and TF2. Pie charts summarize FACS data. Numbers denote
percent cells in the S-phase of the cell cycle. Each value is the average of triplicate data points. Representative FACS dot plots are shown for control
(left of corresponding pie chart) and TF2-cocultured cells (right of corresponding pie chart). Note varying effects of stromal coculture on tumor cell
cycling. B. Measurement of S-phase kinetics over time in representative grade 1 and grade 3 cell lines in the presence of TF1 and TF2 cells. Note
contrasting effects of stromal cells on the replication rate of cell lines shown. Error bars represent standard deviation of the average of triplicate
values. Fibroblast-induced decrease in BrdU labeled cells in grade 1 tumor cells, and a corresponding increase in grade 3 tumor cells was significant at
all time points (p,0.005, and p,0.001, respectively).
doi:10.1371/journal.pone.0020016.g003
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and supportive of differential clinical outcome data derived
through correlative FTExT profiling analysis of primary breast
cancer. Together, they provide a novel conceptual framework for
the significant association between the FTExT expression pattern
in moderately and poorly differentiated or grade 2 and 3 tumor
respectively, and the role of the stroma in the induction of rapid
growth and poor clinical outcome. In contrast, checkpoint
induction in well differentiated or grade 1 tumor cells mediated
by stromal signaling corresponds to the observed gene expression
pattern of primary tumors, which confer a good clinical outcome
(Figure 5B).
Discussion
Towards a complete picture of cancer development and
progression, a comprehensive delineation of underlying sources
contributing to the manifestation of malignant phenotypes and
their heterogeneity, is critical. In previous studies we have uniquely
identified intrinsic phenotypes reflecting histologic tumor variabil-
ity but independent of contextual influences, such as stromal
induction [21]. By employing experimental coculture in conjunc-
tion with novel primary tumor cell lines, here our approach has
identified FTExT, a programmed response to stromally secreted
factors. Instead of a stromal impact that uniformly promotes or
inhibits all tumors, our data demonstrate the significance of
variable epithelial responsiveness in disease outcome. Together
with correlative analyses of clinical tissue, such focused yet broad-
scope investigative strategies to define the functional framework of
cancer phenotypes could substantially improve the range and
accuracy of druggable target identification.
The FTExT profile generated through experimental coculture
portrays stromal regulation of major biological programs,
suggesting a key role for stroma-assisted promotion of early
hallmarks of cancer encompassing evasion of regulatory circuits,
such as immune surveillance, oxidative stress, and metabolic
deficiency [24], in addition to the hallmarks of advanced cancer
[25]. Consequently, the FTExT expression profile was found to be
associated with a poor clinical outcome in two independent
datasets, representing over 600 cases. Consistent with this
correlative clinical data, we have further demonstrated, that the
downstream functional effects of stromally induced transcriptional
changes were dramatically variable between primary breast tumor
cells of divergent histopathologic derivation. In aggressive breast
cancer cells, tumor-promoting effects were evident as an increased
ability for oxidative stress neutralization, apoptosis evasion, and
rapid cell cycling. In contrast, non-aggressive cells displayed the
consequences of negative growth regulation or tumor inhibitory
effects in response to paracrine interaction. It can thus be
concluded that FTExT is a functionally validated surrogate for
measuring the impact of stromal signaling on malignant
epithelium within cancerous breast tissue. Based on a consistent
pattern of responsiveness irrespective of the source of breast
fibroblasts, our data suggest that contrasting responses of
malignant cells are characteristically ‘hard wired’ into the tumor
cell genome. We have previously demonstrated that 2/3 novel
high grade cell lines in this study cluster with other well-known
luminal cell lines [21]. In contrast, our low and intermediate grade
cell lines cluster apart from all other established cell lines,
suggesting the possibility that the unique responsiveness of such
novel breast cancer cell lines to stromal signaling reflect a distinct
molecular makeup. Reflecting a model of ‘effective cooperativity’,
neighboring stroma within malignant tissue plays the role of a key
accomplice, but only to the tumor epithelium armed with
significant biological derangement. Consequently, treatment
strategies could be better informed by the early detection of those
responsiveness patterns wherein stromal interaction promotes
tumor survival and growth at the expense of the host.
In terms of relevance to histologic grade, this is the first report of
a functionally mediated, stromally induced molecular component
associated with global prognostic profiles of grade 2 and 3 tumors.
Grade is an important histologic determinant of patient manage-
ment. More recently, in attempts to eliminate the subjectivity
underlying its histologic assignment, a molecular grade gene index
has been implemented [26,27] based on genes, which are
predominantly associated with tumor cell proliferation [28]. The
Table 2. Cell cycle distribution.
Cell line No coculture TF1 coculture TF2 coculture
G1 S G2/M G1 S G2/M G1 S G2/M
No change in %S-phase
CCdl22 43.96 38.87 16.53* 49.88 21.49 26.38* 46.91 25.91 24.95*
CCdl68 73.70 20.80 3.75 72.80 23.59 2.9 79.63 16.57 3.63
CCdl1570 69.22 24.19 4.5 73.20 20.79 4.49 73.50 17.89 5.90
%S-phase increase
CCdl66 57.14 34.91* 4.81 30.03 62.53* 4.52 23.82 69.46* 4.38
CCdl329 48.84 36.85* 10.26 32.17 62.37* 4.49 27.75 67.52* 3.51
CCdl1599 49.96 36.40* 11.44* 33.35 42.55* 22* 34 43.68* 19.40*
CCdl54 45.58 43.75* 10.02 22.34 72.89* 3.69 21.74 73.09* 2.27
CCdl257 42.84 45.52* 7.85 28.02 68.84* 2.23 25.03 71.92* 1.07
CCdl675 40.08 51.44* 8.06 20.26 74.45* 2.39 16.12 77.79* 4.46
CCdl1797 62.94 29.16* 3.01 39.83 52.57* 1.55 39.90 54.54* 1.5
Text style in column 1 indicates pathologist assigned histologic grade of the original primary tumor source of each cell line. Low grade – Regular; Intermediate grade –
italics; High grade – bold.
Asterisks represent p,0.005 between control and coculture values within each row.
SubG1 values (range between 0–6%, unchanged by coculture) are included in the % calculation. The combined values of all phases=100%.
doi:10.1371/journal.pone.0020016.t002
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distinguishing those grade 2 and 3 tumors that do not confer an
expected poor outcome, could further assist in improving the
reliability of tumor grading and prognostic assessment. Our model
maintains that in indolent breast tumors, where differentiation
signaling is relatively intact, stromal fibroblasts and malignant cells
are not engaged in growth promoting ‘cooperation’. On the other
hand, the loss of responsiveness to differentiation cues in grade 3
and some grade 2 lesions induces a dramatic shift in the epithelial-
stromal dialog towards tumor promotion. It could be argued that
generally at advanced stages, grade 3 cancer displays low stromal
cellularity, and therefore crosstalk between malignant cells and
other components of the tumor, is marginal. In such tumor cells,
repression of FTExT genes might be an inherent phenotype
independent of stromal signaling. While this possibility cannot be
categorically eliminated at this time, our experimental data
demonstrating that cells derived from grade 3 tumors harboring
phenotypes of poor prognosis [21] are indeed promoted further in
Figure 4. Fibroblast-induced apoptosis evasion, oxidative stress reduction, and inhibition of growth arrest in primary tumor cell
lines. A. Reduction in baseline apoptotic fraction measured as Annexin-V positive cells by FACS analysis. Three independent tumor cell lines were
cocultured with nonmalignant (EF), and tumor-derived (TF1) and (TF2) fibroblasts, and compared to tumor alone control cultures for changes in the
apoptotic index. Representative FACS profiles underlying the graphical summaries and percent Annexin-V positive cells are shown. Note significant
decrease in the apoptotic fraction of all 3 tumor lines (*p,0.005). B. Resistance to OHT-induced apoptotic death in tumor cells cocultured with EF
and TF samples compared to drug-treated tumor alone control. Note remarkable repression of OHT-induced cell death by coculture. C. Neutralization
of cellular ROS levels measured as C400 mean fluorescence intensity (MFI) by FACS analysis. Results are expressed as percent reduction over baseline
fluorescence of control tumor cultures vs. cocultures. Representative FACS profiles representing the graphical summaries and MFI values are shown.
Note decline in OHT-induced C400 MFI of all tumor lines (*p,0.005). D. Coculture induced override of OHT-mediated G1 arrest in tumor cells. Note
reduction in percent OHT-induced increase of the G1 population in cocultured tumor cell lines (*p,0.005). Each data point is an average of triplicate
values in all panels of the figure. Bars are color coded in panels B and D to represent the following: gray -untreated control, black – OHT-treated
control, white – OHT treatment of EF coculture, blue – OHT treatment of TF1 coculture, red – OHT treatment of TF2 coculture.
doi:10.1371/journal.pone.0020016.g004
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strongly supportive of a stromal role. In an alternate scenario,
the molecular profile characteristic of high histologic grade is
established early in tumorigenesis partially through stromal
interaction, and maintained thereafter. An example closely
supporting our model of interactive cooperativity is that of dermal
fibroblasts, which repressed the growth of non-metastatic mela-
noma lesions while proliferation of metastatically competent
melanoma cells was stimulated in their presence [29]. In this
light, it could be speculated that FTExT might play a role in the
increased risks associated with mammographic breast density
[30,31] based on the rationale that overabundance of ‘cooperative’
fibroblasts associated with responsive premalignant or malignant
cells leads to more aggressive lesions. This is also consistent with
the finding that carcinomas that exhibit a greater stromal reaction
manifested microscopically as a ‘‘desmoplastic response’’ are
associated with higher histologic grade and poor patient outcome
[32].
Intriguingly, considerable variability in signal induction and/or
elicited response appears to occur between cancer-associated
Figure 5. Reversibility of coculture-induced changes in cell cycle. A. Comparative cell cycle profiles of grade 1 and grade 3 tumor cells after
7-day fibroblast coculture, followed by a 48 hr period without coculture. Note marked reduction in the G2 population of the grade 1 cell line upon
termination of coculture conditions. Both control and test populations display signs of G0/G1 arrest due to culture confluence. In the grade 3 tumor
line, post coculture cell cycling returns to control profiles. Numbered pie chart segments indicate the percentage of cells in G1 and S phase. SubG1:
yellow; G1: green; S: red; G2/M: blue. B. The FTExT model: through the application of live interactive cocultures of stromal fibroblasts and primary
tumor-derived epithelium of varying histologic grade, FTExT offers novel insights into the biological basis of grade-associated stratification of primary
breast cancer. It proposes that cell lines derived from well-differentiated tumors associated with good clinical prognosis recapitulate their functional
characteristics in the presence of stromal fibroblasts in vitro. Similarly, tumor cells derived from poorly differentiated malignant lesions retain the
contextual ability to respond to the same paracrine influence in a manner corresponding to cancer aggressiveness and unfavorable patient outcome.
Such authentic model systems are an essential tool for advancing the goals of research in cancer biology.
doi:10.1371/journal.pone.0020016.g005
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of specificity in the crosstalk between stromal and malignant cells
of diverse tissue origin. With regard to 26 probe sets common
between the coculture transcriptional profiles in our study and
myeloma cells cocultured with bone marrow derived stromal cells
[33], 25 probe sets displayed suppression in the FTExT profile, but
in remarkable contrast their expression was induced in myeloma
cocultures. Such inter-study comparisons are invaluable and
underscore the importance of well-defined model systems for the
derivation of clinically relevant data for each tumor type. As a
striking example of tissue specific effects, although loss of function
for PTEN, a FTExT gene, is a well-known indicator of tumor
aggressiveness [34], this carcinoma-associated tumor suppressor
gene appears to be overexpressed in myeloma patients with poor
clinical outcome [33]. Similar contrasting patterns of expression
were noted underlying the role of FTExT genes: CYBA, GNAI2,
GRN, JAK3, TRADD, BCL2A1, BPGM, and CD48 in
carcinomas of the breast and other tissues, in comparison to
myeloma. However, both in myeloma as well as in breast cancer,
signatures portraying altered functionality due to paracrine
exchange between stromal and tumor cells, were characteristic
of poor clinical outcome, suggesting similar underlying pathways
albeit transcriptionally distinctive. The fact that although stroma
of different tissues regulate a closely similar set of genes, but in
opposing directions in two tumor types, might reflect contrasting
functions of their precursor cell types - epithelium vs. B
lymphocytes, in this case. This is a critical finding in and of itself,
emphasizing careful consideration prior to data extrapolation from
one cellular subset or tissue type to another. Thus caution must be
exercised in employing irrelevant cell types and their modulating
microenvironment in highly cost-intensive drug discovery efforts.
In a similar vein, it is notable that the FTExT signature includes
several genes characteristic of immune response. While the
induction of these genes in tumor tissue confers a favorable
prognosis in breast cancer patients [35,36], it is consistent that
their repression would have the reverse effect as demonstrated by
our data and by others [37].
Our approach complements profiling strategies for identifying
the biological basis of the clinical heterogeneity of human
malignancy in general, and breast cancer in particular, but differs
in the striking innovation of engaging functional cell models
spanning the clinicopathologic spectrum of this disease. The need
for hypothesis validation through gene-by-gene manipulation of
cellular and rodent models, severely limited in the representation
of the full range of human cancer pathology, is thus circumvented.
Portrayed as dynamic paracrine interactions, which lead to the
clinical, molecular, and functional heterogeneity of breast cancer,
our data present novel opportunities for tumor targeting. Thus,
therapies that enable the disruption of cancer-promoting interac-
tions in the malignant microenvironment could serve as an
important adjunct to current approaches, which only target
malignant subpopulations to a variable degree. The observation
that secreted stromal factors are remarkably effective in modulat-
ing tumor phenotypes brings a long desired goal in the field closer
to fruition, whereby the detection of tumor associated markers in
body fluids could be facilitated in the future. Concerted efforts
towards the identification of stromal signals that fuel dramatic
changes represented by the FTExT profiles of tumor cells should
be a priority for impeding such crosstalk in high risk tumors, such
as triple-negative breast cancer. In this regard, previous investi-
gations of microdissected fibroblasts and tumor cells within
archived breast tumor tissue have indeed demonstrated charac-
teristic features of stromal and epithelial cell lineages [38], but not
distinguished between inherent and induced characteristics of each
subset, thus only partially addressing their respective role in the
overall tumor phenotype. On the other hand, an inducible model
of squamous cell carcinoma highlighted the importance of tumor-
stroma interaction and identified the temporal induction of ß1
integrin as a potential nexus involved in Ras-driven tumor
progression [39], but functional dissection of inter-tumor hetero-
geneity was not a major goal. Among those that could benefit
considerably from targets manifested early in tumorigenesis are
women that harbor DCIS, currently the most common diagnosis
in the Western world associated with breast related symptoms
[40]. Since DCIS is a preinvasive lesion, and often indolent, it
presents the clinician with the dilemma of distinguishing between
those that will recur with invasive disease, thus requiring
immediate aggressive therapeutic measures, from those that will
not. As suggested by the FTExT signature, stromally induced cues
might promote the release of in situ tumor cells from the confines of
the basement membrane, as well as support subsequent steps in
tumor survival and expansion. Thus, detection of FTExT-related
aberrations within diagnostic biopsies could improve clinical
decision-making, and offer clear opportunities for personalized
patient management.
Methods
Cell culture
The development of spontaneously immortalized high grade,
and non-spontaneously immortalized, hTERT-transduced low
and intermediate grade primary breast cancer cell lines has been
previously described [41]. All primary tumor cell lines were
maintained in MCDB 170 growth medium supplemented with 2%
FBS. Collection of surgical discard tissue and of non-malignant
breast epithelial cells as random periareolar fine needle aspirates
(RPFNA) from unafflicted contralateral breast tissue of patients
undergoing surgical procedures for benign or malignant disease
was reviewed and approved by the California Pacific Medical
Center Institutional Review Board. All human subjects signed
informed consent forms prior to sample collection. Microarray
analysis conducted on samples without patient identifiers was
approved by the Stanford University Human Subjects Research
Compliance Board. Epithelial cells within RPFNA cells were
propagated as previously described [42]. Fibroblast cultures
derived from mechanically and enzymatically dissociated surgical
discard primary breast tumor, or reduction mammoplasty tissue,
were routinely propagated in DME+10% FBS. In the coculture set
up, epithelial cells were seeded in 6-well plates, and second to third
passage fibroblast cells in 0.4 mm inserts with hanging geometry
(BD Biosciences, Franklin Lakes, NJ) at a 3:1 ratio in a common
pool of MCDB 170 growth medium for 3-day harvests. Controls
were comprised of each epithelial sample maintained in the
absence of fibroblast-seeded inserts under the same culture
conditions.
Array analysis and data preprocessing
Gene expression analyses were performed on epithelial tumor
cells removed from 3-day coculture with stromal fibroblast inserts
within 6-well plates, and compared to non-cocultured epithelial
tumor cells in independent 6-well plates processed simultaneously.
Tumor cell RNA was isolated with the RNeasy kit (Qiagen,
Valencia, CA) and applied towards global gene expression
profiling using Human Genome U133 Plus 2.0 arrays (Affymetrix,
Santa Clara, CA). Raw CEL files were processed using Affymetrix
Expression Console by the robust multichip analysis (RMA)
method with default parameters [43]. Significant genes were
inferred using linear regression models in the limma R package of
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model of base-line expression, an individual tumor cell line effect
and a coculture effect. Genes with significant coculture effects were
selected as signatures between tumor only and cocultured samples.
Statistical significance was adjusted by multiple hypotheses testing
with the Benjamini-Hochberg procedure [45]. Fold changes
between tumor cells with and without coculture were calculated
from the gene expression data adjusted by removing individual
tumor cell line effects. The microarray data in this report is
MIAME compliant and the raw data can be accessed under
GSE27018 in the NCBI Gene Expression Omnibus database.
Biological functions of the significant genes were derived by
Ingenuity Pathway Analysis tools (www.ingenuity.com).
Classification and survival analysis
A classifier was built upon 107 significant probe sets with fold
changes .2 for two classes, like-T (similar to tumor cells only) and
like-T+TF (similar to tumor cells cocultured with fibroblasts). The
classification power was tested over two independent data sets,
GSE6532 (n=401) and GSE11121 (n=200). A classification score
of each sample was calculated as the projection of an expression
profile to the first principle component of the standardized
expression matrix of a training set, the FTExT data. The class of a
tested sample was determined as the closest class in terms of
Gaussian distance of the sample’s classification score to the
centroid of each class in the training set. Univariate analyses of the
predicted class, and conventional prognostic factors were per-
formed with the Cox proportional hazard regression model.
Survival of patient groups was visualized with Kaplan-Meier
curves, and compared using the log-rank test.
Real time quantitative PCR (QPCR) analysis
RNA from 6 independent sets of tumor epithelial-stromal
cocultures was used to validate expression patterns of 11 top SAM
genes. Total RNA was isolated using the RNeasy kit (Qiagen) from
tumor cells cultured alone or as cocultures with tumor fibroblasts
for 7 days. RNA concentrations were determined by NanoDrop
2000 (Thermo Fisher Scientific, Waltham, MA). cDNA was
synthesized and analyzed as before [21] by an Applied Biosystems
5700 Sequence Detection System (Foster City, CA). The Ct values
of test genes were normalized to the expression of the
housekeeping gene, ACTB, within each sample to represent log
base 2 fold increase or decrease in test gene expression over no
coculture controls. Primer sequences for test genes are listed in
Table S2.
Quantitation of endogenous reactive oxygen species
(ROS)
Endogenous cellular ROS accrual was determined as previously
described [46] using live tumor cultures loaded with the
fluorogenic dye, Carboxy-H2DCFDA (5-(and-6)-carboxy-2979-
dichlorodihydrofluorescein diacetate), also known as C400 (In-
vitrogen, Carlsbad, CA) for 1 hr. After dye removal, cells were
counterstained with propidium iodide (PI), and intracellular
oxidation of C400 was measured by FACScan (BD Biosciences)
with the FL1 filter. Experiments were done in triplicate and
10,000 cells were acquired for each sample. ROS activity was
expressed as mean fluorescence intensity (MFI) of the C400 dye.
MFI of PI-negative (non-necrotic) cells was corrected for
autofluorescence.
Analysis of apoptotic cell death
Apoptosis was induced in tumor cells after removal from
coculture wells by a 24 hr treatment with 10 mM 4-hydroxyta-
moxifen (OHT). Parallel controls were maintained for 24 hours
without OHT. For quantitation of OHT-induced apoptotic cell
death, cultures were harvested and stained with Annexin V-FITC
and PI (BD Biosciences) according to the manufacturer’s protocol.
Cells diluted in binding buffer were analyzed by FACScan and
quantified by CellQuest software (BD Biosciences). Annexin-V
positive cells were measured as early (PI-negative) and late (PI-
positive) apoptotic cell fractions. Each measurement was per-
formed in multiple replicates. Results were expressed as percent of
control (OHT-treated without prior coculture).
Cell cycle kinetics
Tumor cells were exposed to malignant or nonmalignant breast
tissue-derived fibroblasts, or maintained as control cells without
coculture. At the end of the coculture period, fibroblast-bearing
inserts were removed and tumor cells were pulse-labeled with
10 mM BrdU for varying time periods (20–60 minutes), stained
with anti BrdU (Santa Cruz Biotechnology, Santa Cruz, CA),
FITC-conjugated secondary antibody (Invitrogen), counterstained
with PI, and analyzed by FACScan.
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